The historical rank and industry rank for Staar Surgical Co's OCF Margin % or its related term are showing as below:
STAA'
s OCF Margin % Range Over the Past 10 Years
Min: -14.3 Med: 7.66 Max: 19.07
Current: -17.28
During the past 13 years, the highest OCF Margin % of Staar Surgical Co was 19.07%. The lowest was -14.30%. And the median was 7.66%.
STAA's OCF Margin % is ranked worse than 74.23% of 815
companies
in the Medical Devices & Instruments industry
Industry Median: 5.86
vs STAA: -17.28
Staar Surgical Co OCF Margin % Related Terms
Staar Surgical Co OCF Margin % Historical Data
* Premium members only.
The historical data trend for Staar Surgical Co's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, Staar Surgical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Staar Surgical Co OCF Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Staar Surgical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Staar Surgical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Staar Surgical Co (STAA) has a OCF Margin % of -23.20% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Staar Surgical Co and its competitors. According to the industry distribution chart, Staar Surgical Co ranks #605 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 74.2%.
Is Staar Surgical Co's OCF Margin % too high?
Staar Surgical Co's current OCF Margin % is -23.20%. Based on the distribution chart, Staar Surgical Co ranks #605 out of 815 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Staar Surgical Co has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Staar Surgical Co's OCF Margin % compare to NNNN and ATRC?
According to the Medical Devices & Instruments industry distribution chart, Staar Surgical Co ranks #605 out of 815 companies for OCF Margin %. This places Staar Surgical Co in the lower half of its industry. The industry median OCF Margin % is 5.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Medical Devices & Instruments company?
The median OCF Margin % among Medical Devices & Instruments companies is 5.86, based on 815 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Staar Surgical Co and its competitors. For the Medical Devices & Instruments industry, the median OCF Margin % is 5.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Staar Surgical Co's current OCF Margin % is -23.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Staar Surgical Co stock overvalued right now?
Based on GuruFocus' analysis, Staar Surgical Co (STAA) is currently considered Fairly Valued. The stock's GF Value™ is $31.39, compared to a current price of $29.29 — trading 6.7% below its estimated fair value. The current OCF Margin % is -23.20%. Staar Surgical Co's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Staar Surgical Co (STAA), the current OCF Margin % is -23.20% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Staar Surgical Co (STAA) Overvalued in 2026?
Based on GuruFocus' analysis, Staar Surgical Co stock appears to be undervalued.
The current stock price of $29.29 is trading 6.7% below its estimated GF Value™ of $31.39.
GuruFocus considers Staar Surgical Co to be Fairly Valued.
Key valuation signals for STAA:
OCF Margin %: -23.20%
GF Value™: $31.39 vs. price of $29.29 (6.7% below fair value)
No single metric tells the full story. See the STAA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Staar Surgical Co is a manufacturer of lenses. It designs, develops, manufactures, and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company offers two types of products: Implantable Collamer lenses (ICL), which are used in refractive surgery. The company generates almost all of its revenue from the sale of its ICL products. Geographically, the company generates key revenue from Foreign sales.
79GF Score
Get the complete analysis for STAA
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STAA has been successfully added to your 
